GSTP1 and Familial prostate cancer: Thus, the over-representation of GSTP1-positive prostate cancer in Black men may render them less responsive to taxane chemotherapy, which is the preferred chemotherapy for advanced, lethal metastatic castration resistant prostate cancer [5].